Genetic insights into the association between inflammatory bowel disease and Alzheimer’s disease

Lu Zeng,Charles C. White,David A. Bennett,Hans-Ulrich Klein,Philip L. De Jager

DOI: https://doi.org/10.1101/2023.04.17.23286845

2024-10-25

Abstract:Background: Myeloid cells, including monocytes, macrophages, microglia, dendritic cells and neutrophils are a part of innate immunity, playing a major role in orchestrating innate and adaptive immune responses. Microglia are the resident myeloid cells of the central nervous system, and many Alzheimer's disease (AD) risk loci are found in or near genes that are highly or sometimes uniquely expressed in myeloid cells. Similarly, inflammatory bowel disease (IBD) loci are also enriched for genes expressed by myeloid cells. However, the extent to which there is overlap between the effects of AD and IBD susceptibility loci in myeloid cells remains poorly described, and the substantial IBD genetic maps may help to accelerate AD research. Methods: Here, we leveraged summary statistics from large-scale genome-wide association studies (GWAS) to investigate the causal effect of IBD (including ulcerative colitis and Crohn's disease) variants on AD and AD endophenotypes. Microglia and monocyte expression Quantitative Trait Locus (eQTLs) were used to examine the functional consequences of IBD and AD risk variants enrichment in two different myeloid cell subtypes. Results: Our results showed that, while PTK2B is implicated in both diseases and both sets of risk loci are enriched for myeloid genes, AD and IBD susceptibility loci largely implicate distinct sets of genes and pathways. AD loci are significantly more enriched for microglial eQTLs than IBD. We also found that genetically determined IBD is associated with a lower risk of AD, which may driven by a negative effect on the accumulation of neurofibrillary tangles (beta=-1.04, p=0.013). In addition, IBD displayed a significant positive genetic correlation with psychiatric disorders and multiple sclerosis, while AD showed a significant positive genetic correlation with amyotrophic lateral sclerosis. Conclusion: To our knowledge, this is the first study to systematically contrast the genetic association between IBD and AD, our findings highlight a possible genetically protective effect of IBD on AD even if the majority of effects on myeloid cell gene expression by the two sets of disease variants are distinct. Thus, IBD myeloid studies may not help to accelerate AD functional studies, but our observation reinforces the role of myeloid cells in the accumulation of tau proteinopathy and provides a new avenue for discovering a protective factor.

Genetic and Genomic Medicine

What problem does this paper attempt to address?

The paper attempts to address the question of whether there is a genetic association between inflammatory bowel disease (IBD) and Alzheimer's disease (AD), and to analyze the specific mechanisms of these associations. Specifically, the researchers use genome-wide association studies (GWAS) and expression quantitative trait loci (eQTL) data to investigate the impact of genetic variations in IBD (including ulcerative colitis UC and Crohn's disease CD) on AD and its phenotypes. Through these analyses, the researchers hope to reveal whether these two diseases share certain genetic risk factors and how these factors affect the function of different types of myeloid cells (such as microglia and monocytes).

The main research questions include:
1. **Genetic Association**: Do genetic variations in IBD affect the risk of AD?
2. **Functional Consequences**: What are the functional consequences of these genetic variations in myeloid cells?
3. **Subtype Specificity**: Do different subtypes of IBD (UC and CD) have different impacts on AD?
4. **Protective Effect**: Does the genetic predisposition to IBD have a protective effect, reducing the risk of AD?

By answering these questions, the researchers hope to provide new insights into the prevention and treatment of these two diseases.